Download Citation
Article Source:
A Novel Proteomics-Based Clinical Diagnostics Technology Identifies Heterogeneity in Activated Signaling Pathways in Gastric Cancers
Lee J,
Kim S,
Kim P,
Liu X,
Lee T,
et al.
(2013)
A Novel Proteomics-Based Clinical Diagnostics Technology Identifies Heterogeneity in Activated Signaling Pathways in Gastric Cancers.
PLOS ONE 8(1): e54644.
https://doi.org/10.1371/journal.pone.0054644